Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

EHU051441

Sigma-Aldrich

MISSION® esiRNA

targeting human NOV

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

description

Powered by Eupheria Biotech

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

CCCAGGGCAAATAGTCAAGAAGCCAGTGATGGTCATTGGGACCTGCACCTGTCACACCAACTGTCCTAAGAACAATGAGGCCTTCCTCCAGGAGCTGGAGCTGAAGACTACCAGAGGGAAAATGTAACCTGTCACTCAAGAAGCACACCTACAGAGCACCTGTAGCTGCTGCGCCACCCACCATCAAAGGAATATAAGAAAAGTAATGAAGAATCACGATTTCATCCTTGAATCCTATGTATTTTCCTAATGTGATCATATGAGGACCTTTATATCTGTCTTTTATTTAACAAAAAATGTAATTAACTGTAAACTTGGAATCAAGGTAAGCTCAGGATATGGCTTAGGAATGACTTACTTTCCTGTGGTTTTATTACAAATGCAAATTTCTATAAATTTAAGAAAACAAGTATATAATTTACTTTGTAGACTGTTTCACATTGCACTCATCA

Ensembl | human accession no.

ENSG00000136999

NCBI accession no.

NM_002514

shipped in

ambient

storage temp.

−20°C

Gene Information

human ... NOV(4856) , NOV(4856)

Related Categories

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Po-Chun Chen et al.
Oncotarget, 8(43), 74506-74518 (2017-11-02)
Epithelial-mesenchymal transition (EMT) has received considerable attention as a conceptual paradigm for explaining metastatic behavior during cancer progression. NOV/CCN3 is a matrix-associated protein involved in many cellular functions. Previous studies have shown that CCN3 expression is upregulated in prostate cancer
Jason R Dobson et al.
Cancer cell international, 14, 73-73 (2014-08-15)
For treatment and prevention of metastatic disease, one of the premier challenges is the identification of pathways and proteins to target for clinical intervention. Micro RNAs (miRNAs) are short, non-coding RNAs, which regulate cellular activities by either mRNA degradation or

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service